Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATV/RTV + 3TC vs ATV/RTV + TDF/FTC in Treatment-Naïve HIV-1
NCT01620944Phase 3Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Bristol Myers Squibb. Started Jul 2012; status: terminated.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01620944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620944.